Evento

Combined treatment of trilostane and retinoic acid in dogs with Pituitary-Dependent Hypercortisolism

Miceli, Diego DanielIcon ; Vidal, Patricia NoemiIcon ; Pignataro, Omar PedroIcon ; Castillo, V. A.
Colaboradores: Luckschander Zeller, Nicole
Tipo del evento: Congreso
Nombre del evento: 30th ECVIM-CA Annual Congress
Fecha del evento: 02/09/2020
Institución Organizadora: European College of Veterinary Internal Medicine - Companion Animals;
Título de la revista: Journal Of Veterinary Internal Medicine
Editorial: Wiley-liss, div John Wiley & Sons Inc.
ISSN: 0891-6640
e-ISSN: 1939-1676
Idioma: Inglés
Clasificación temática:

Resumen

Pituitary-Dependent Hypercortisolism (PDH) is a severe metabolic disorder and represents 80-85% of cases of spontaneous hypercortisolism in dogs. Trilostane is a potent inhibitor of an early stage of adrenal steroidogenesis, but has no therapeutic effects on pituitary tumor.
Palabras clave: HYPERADRENOCORTICISM , TRILOSTANE , RETINOID ACID , CUSHING´S DISEASE
 
Archivos asociados
Thumbnail
 
Tamaño: 562.6Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/255733
URL: https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15924
DOI: http://dx.doi.org/10.1111/jvim.15924
URL: https://www.ecvimcongress.org/history_congresses/previous_congresses
Colecciones
Eventos(IBYME)
Eventos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Citación
Combined treatment of trilostane and retinoic acid in dogs with Pituitary-Dependent Hypercortisolism; 30th ECVIM-CA Annual Congress; en línea; Países Bajos; 2020; 3092-3093
Compartir
Altmétricas